BI-CARZEM SR is a brand name for a sustained-release formulation of diltiazem, which is a calcium channel blocker used primarily in the management of hypertension (high blood pressure), angina pectoris (chest pain), and certain types of arrhythmias (irregular heartbeats). By inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle during depolarization, diltiazem causes vasodilation, leading to a decrease in blood pressure and a reduction in the heart's workload. The sustained-release (SR) formulation of BI-CARZEM allows for a more consistent release of the medication over time, providing a stable therapeutic effect and potentially reducing the frequency of dosing compared to immediate-release formulations. This can improve patient compliance and overall treatment outcomes. As with any medication, it is important to use BI-CARZEM SR under the guidance of a healthcare professional to ensure its safe and effective use.